baber/WOPTO huggingface dataset:
Patent AU-2011219151-A1 (AU)
Title: Composite semipermeable membrane and process for production thereof
Inventor: OGAWA TAKAFUMI
IPC: B01D69/12
Filed: 2011-02-17
Abstract: Disclosed is: a composite semipermeable membrane comprising a polyamide separation functional layer arranged on a microporous support film, wherein the polyamide separation functional layer has a degree of yellow ting of 10 to 40 inclusive and the actual length of the polyamide separation functional layer per 1 μm of the microporous support film is 2 to 5 μm inclusive; or a composite semipermeable membrane comprising a polyamide separation functional layer arranged on a microporous support film and produced by the polycondensation of a polyfunctional amine with a polyfunctional acid halide, wherein the polyamide separation functional layer is produced through the steps of (A) an interfacial polycondensation step of bringing the polyfunctional amine into contact with the polyfunctional acid halide at 40 to 70˚C and (B) a step of a heating treatment at 70 to 150˚C. The composite semipermeable membrane has high boron removal performance and high water permeability.
Patent AU-2011221417-A1 (AU)
Title: Forceps with spring loaded end effector assembly
Inventor: DUMBAULD PATRICK L
IPC: A61B17/28
Filed: 2011-09-09
Abstract: FORCEPS WITH SPRING LOADED END EFFECTOR ASSEMBLY A vessel or tissue sealing instrument (10), comprising a handle assembly (18) having an elongated shaft (12) extending therefrom, the shaft (12) movable relative to the handle assembly (18) by an actuator (20), an end effector assembly (100) attached to a distal end of the shaft (12), the end effector assembly (100) having first and second jaw members (110, 120) movable about a pivot from a first position in spaced relation relative to one another to a second position for clamping tissue, wherein each of the jaw members (110, 120) includes an insulative outer housing (124) having an electrically conductive, inwardly-facing tissue contacting surface (112), a proximal flange (130) having at least one camming surface (134, 144) disposed proximal to the pivot (219), the proximal flange (130) including a spring-like tail (235, 245) that mounts within the distal end of the elongated shaft (12) to bias the jaw members (110, 120) in an open configuration, wherein a proximal portion of the spring-like tail (235, 245) is biased radially outward within the distal end of the elongated shaft (12) and wherein the proximal flange (130) cooperates with the distal end of the elongated shaft (12) to provide a clamping pressure to effectively seal tissue upon application of electrosurgical energy, the actuator (20) movable relative to the handle (28) to actuate the elongated shaft (12) from a first position wherein the elongated shaft (12) remains proximal to the proximal flanges (130) of the jaw members (110, 120) and the jaw members (110, 120) are biased in an open configuration to at least one subsequent position wherein the distal end of the elongated shaft (12) cams the proximal flanges (130) to pivot the jaw members (110, 120) toward the second position to clamp tissue. 5581278-1:EEB
Patent AU-2011224062-A1 (AU)
Title: Method of using gelled fluids with defined specific gravity
Inventor: CASEY GREGORY E
IPC: C09K8/504
Filed: 2011-09-15
Abstract: Gelled barrier fluids preventing the ingress of undesired fluids from subsurface environments into subsurface apparatus have a specific gravity which is within ± 0.05 of the specific gravity of the undesired fluid. 10,901,885
Patent AU-2011224714-A1 (AU)
Title: Interlocking reverse hip and revision prosthesis
Inventor: TERMANINI ZAFER
IPC: A61F2/32
Filed: 2011-02-23
Abstract: A reverse hip prosthesis comprising an acetabular cup for implanting in an acetabular socket. The acetabular cup is secured to the acetabular socket of the pelvis using fasteners. The acetabular cup has a stem extending from the center of a concave portion thereof and an acetabular ball is attached to the stem, preferably by means of a Morse taper. A femoral implant is provided with a femoral cup attached to the proximal end thereof. The femoral cup has a stem which can be constructed in a modular fashion with several stem lengths in order to accommodate the various sizing requirements of different patients. After implantation of the acetabular cup and ball and the femoral cup, the members are assembled together so that the femoral cup can articulate on the acetabular ball. The prosthesis of the invention has a wide range of motion and substantially improved tribology. As the femoral cup is articulated, the edge of the femoral cup moves into a space located between the acetabular cup and the acetabular ball and thereby becomes restrained, thus reducing the likelihood of dislocation during extreme ranges of motion.
Patent AU-2011227232-A1 (AU)
Title: Arylsulfonamide CCR3 antagonists
Inventor: LY TAI WEI
IPC: A61K31/4468
Filed: 2011-03-17
Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3 -mediated disorder, disease, or condition.
Patent AU-2011239689-A1 (AU)
Title: Human FGF receptor and beta-Klotho binding proteins
Inventor: FACHINI ROGER
IPC: C07K16/28
Filed: 2011-04-13
Abstract: The present invention provides compositions and methods relating to or derived from antigen binding proteins and antigen binding protein-FGF21 fusions that specifically bind to β-Klotho, or β-Klotho and one or more of FGFR1c, FGFR2c, FGFR3c, and FGFR4. In some embodiments the antigen binding proteins and antigen binding protein-FGF21 fusions induce FGF21-like signaling. In some embodiments, an antigen binding protein or antigen binding protein-FGF21 fusion antigen binding component is a fully human, humanized, or chimeric antibody, binding fragments and derivatives of such antibodies, and polypeptides that specifically bind to β-Klotho, or β-Klotho and one or more of FGFR1c, FGFR2c, FGFR3c, and FGFR4. Other embodiments provide nucleic acids encoding such antigen binding proteins and antigen binding protein-FGF21 fusions, and fragments and derivatives thereof, and polypeptides, cells comprising such polynucleotides, methods of making such antigen binding proteins and antigen binding protein-FGF21 fusions, and fragments and derivatives thereof, and polypeptides, and methods of using such antigen binding proteins and antigen binding protein-FGF21 fusions, fragments and derivatives thereof, and polypeptides, including methods of treating or diagnosing subjects suffering from type 2 diabetes, obesity, NASH, metabolic syndrome and related disorders or conditions.
Patent AU-2011250780-A1 (AU)
Title: Modular flooring assemblies
Inventor: JONATHAN MCINTOSH
IPC: E04B2/08
Filed: 2011-11-15
Abstract: PA IENT - PCT Atty Docket No. 112810 ExpressMailNo EV785818154 US Abstract A modular flooding assembly 10 including a flooring component 600 adhered to a tray substrate 100 is described. The modular flooring assembly 10 may be interconnected with additional modular flooring assemblies to form a modular floor suitable for most flooring applications The flooring component 600 may be tile or wood or other materials commonly used in flooring applications Convention fill-in grout or a snap-in grout may be used with the modular flooring assemblies 10 One suitable snap-in grout is a right angle grout member 400. Another suitable snap-in grout is an interconnecting grout system 510 049202 /110896 BBDIE 328619 Page 24
Patent AU-2011250940-A1 (AU)
Title: Markers for acute kidney injury
Inventor: WESTERMAN MARK E
IPC: C12N5/02
Filed: 2011-05-10
Abstract: Provided are methods and compositions for predicting the development of kidney disease, including acute kidney injury. In certain aspects and embodiments the provided methods and compositions are particularly useful for predicting kidney injury following an event likely to cause kidney injury and/or kidney failure in a patient, such as a cardiac surgery, e.g., a surgery involving a cardiopulmonary bypass (CPB), such as a coronary artery bypass graft surgery. In some embodiments, the higher the urinary hepcidin-to-urinary creatinine ratio (uHep/uCr) at 6-24 hours following initiation of CPB, the lower is the risk for development of AKI determined by RIFLE criteria in the ensuing four to five days. Conversely, the higher the urinary NGAL to urinary creatinine ratio (uNGAL/uCr) at 6-24 hours following initiation of CPB, the higher is the risk of developing CPB-mediated AKI over the same time period.
Patent AU-2011253838-A1 (AU)
Title: Measurement system, moving-object-mounted terminal and data processing apparatus
Inventor: WATANABE TSUTOMU
IPC: H04B7/14
Filed: 2011-12-05
Abstract: According to one embodiment, a measurement system includes a wireless relay device, a moving-object-mounted terminal and a data processor. The moving-object-mounted 5 terminal is mounted to a moving object within a wireless area formed by the wireless relay device. The moving object-mounted terminal includes a Global Positioning System (GPS) unit and a wireless unit. The GPS unit acquires positional data of the moving object and time 10 data indicating the time when the positional data has been acquired by GPS. The wireless unit converts the positional data and the time data into a wireless signal, and transmits the wireless signal to the wireless relay device. The data processor receives the wireless signal 15 from the moving-object-mounted terminal via the wireless relay device, and calculates time required for the moving object to move a predetermined distance. 2999148_1 (GHMatters) P88981.AU 5/12/11 0 U) 0 C: ) U> Ca0 8L) 00)) U) C/) L) ) ('3 0)0 0*4 0c) 0 a a--
Patent AU-2011268685-A1 (AU)
Title: Use of an estrogen derivative for the manufacture of pharmaceutical compositions useful for the treatment and/or prevention of psychiatric diseases and for the treatment and prevention of said diseases
Inventor: HAJSZAN TIBOR
IPC: A61K31/565
Filed: 2011-06-28
Abstract: The object of the invention is the use of 17-alpha-estradiol of formula (I) and its derivatives for the treatment and/or prevention of psychiatric clinical pictures. According to the invention, 17-alpha-estradiol and its derivatives can be used preferably as antidepressant drugs, especially preferably as quick-acting antidepressant drugs. According to the invention, 17-alpha-estradiol of formula (I) and its derivatives can also be used for the treatment and/or prevention of postpartum depression, post-menopausal depression, anxiety, schizophrenia, memory disturbance associated with depression or bipolar depression.
Patent AU-2011271263-A1 (AU)
Title: Customizing a search experience using images
Inventor: DUNN MELISSA W
IPC: G06F3/14
Filed: 2011-06-17
Abstract: Systems, methods, and computer storage media having computer-executable instructions embodied thereon that present images customized for a user. In embodiments, a search query input by a user and user data associated with the user are referenced. The search query and/or user data is utilized to select one or more images to display via a display screen. Such an image(s) can be, for example, a background image that is presented as a background to a search results webpage and/or an icon image that represents a category of search results.
Patent AU-2011277201-A1 (AU)
Title: Method and system for multiplexing acknowledgement signals and sounding reference signals
Inventor: NAM YOUNG HAN
IPC: H04B7/26
Filed: 2011-07-14
Abstract: A base station includes a transmit path circuitry that determines a PUCCH format 3 index and transmits an uplink grant to a subscriber station, the uplink grant including an indication of the PUCCH format 3 index. The base station also includes a receive path circuitry that receives a PUCCH format 3 signal in a subframe from the subscriber station. The receive path circuitry also receives a first demodulation reference signal for the PUCCH format 3 signal in the first slot of the subframe, where the first demodulation reference signal is determined based at least partly upon a first demodulation reference signal cyclic shift number. The receive path circuitry also receives a second demodulation reference signal for the PUCCH format 3 signal in the second slot of the subframe, where the second demodulation reference signal is determined based at least partly upon a second demodulation reference signal cyclic shift number.
Patent AU-2011308094-A1 (AU)
Title: Patient interface systems
Inventor: BARLOW ADAM FRANCIS
IPC: A61M16/06
Filed: 2011-09-30
Abstract: A patient interface structure for delivery of respiratory therapy to a patient includes a front plate configured to conform to the shape of the patient's face; a mouth cushion defining a breathing chamber and provided to the front plate and configured to seal around the patient's mouth; and a nasal cushion configured to seal the patient's nasal airways. The nasal cushion is supported by the mouth cushion, does not contact a bridge of the patient's nose in use, and extends at least partially into the breathing chamber. A patient interface system includes a patient interface structure and a patient interface structure positioning system configured to position, stabilize and secure the patient interface structure in sealing engagement with the patient's face.
Patent AU-2011311543-A1 (AU)
Title: Apparatus and method for level estimation of coded audio frames in a bit stream domain
Inventor: GEIGER RALF
IPC: H04N7/15
Filed: 2011-10-06
Abstract: An apparatus for level estimation of an encoded audio signal is provided. The apparatus comprises a codebook determinator (110) for determining a codebook from a plurality of codebooks as an identified codebook. The audio signal has been encoded by employing the identified codebook. Moreover, the apparatus comprises an estimation unit (120) configured for deriving a level value associated with the identified codebook as a derived level value and, for estimating a level estimate of the audio signal using the derived level value.
Patent AU-2011338561-A1 (AU)
Title: Lysophosphatidic acid receptor antagonists and their use in the treatment of fibrosis
Inventor: SEIDERS THOMAS JON
IPC: A61K31/381
Filed: 2011-12-06
Abstract: Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
Patent AU-2011356685-A1 (AU)
Title: Methods and systems regarding models of underground formations
Inventor: YARUS JEFFREY M
IPC: G01V1/00
Filed: 2011-01-27
Abstract: Models of underground formations. At least some of the illustrative embodiments are methods including creating a model of an underground formation. The creating may include: calculating a set of probabilities associated with a first horizontal location, each probability indicative of a likelihood of finding abutting geological layers; estimating a plurality of successions of geological layers to create a plurality of estimated successions, and the estimating using the set of probabilities; determining, for each of the estimated succession, a value indicative of how closely each estimated succession matches a measured succession, the measured succession determined by a seismic survey; and selecting from the plurality of estimated successions based on the values, the selecting creates a selected succession of geological layers, and the plurality of modeled values associated with the first horizontal location determined based on the selected succession of geological layers.
Patent WO-2012103578-A1 (WO)
Title: Transparent infrared absorbing materials
Inventor: SUBRAMANIAN PRIYA
IPC: C08K9/04
Filed: 2012-02-01
Abstract: An infrared absorbing material, an infrared absorbing ink formulation and a method of production are provided in which at least one infrared absorbing dye is supported on nanoparticles having an average size not greater than 100nm in at least one direction. The dye-supporting nanoparticles may be dispersed in a carrier vehicle such that the infrared absorbing material or ink is substantially transparent to visible radiation. The infrared absorbing material and ink are particularly suitable for use in banknotes and other security documents.
Patent AU-2012201613-A1 (AU)
Title: Stabilized amorphous forms of Imatinib mesylate
Inventor: GONCALVES ELISABETE
IPC: A61K9/16
Filed: 2012-03-19
Abstract: Abstract The invention relates to the stabilized amorphous form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin- 1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)-pyrimidin 2-ylamino)-phenyl]-benzamide, pharmaceutical compositions such as capsules or tablets containing this form, the use of such form in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and the use of formulation principles stabilizing the amorphous form of Imatinib mesylate as an intermediate for the preparation of pharmaceutical compositions.
Patent AU-2012202051-A1 (AU)
Title: Assessing neuronal damage from blood samples
Inventor: SHAW GERRY
IPC: G01N33/48
Filed: 2012-04-11
Abstract: Neuronal damage is detected by providing a biological sample derived from the 5 subject, detecting in the sample the presence of a neurofilament subunits or their breakdown products, and correlating the presence and level of the neurofilament subunits and their breakdown products detected with the degree of neuronal injury.
Patent AU-2012202087-A1 (AU)
Title: Foil cartridge and method for producing a foil cartridge
Inventor: WILLNER RALF
IPC: B65D33/36
Filed: 2012-04-11
Abstract: Foil Cartridge and Method for Producing a Foil Cartridge A foil cartridge has a foil tube (106) enclosing at least one chamber (110, 112) in the circumferential direction and a cover (116) separate from the foil tube (106), said cover closing an axial end of the foil tube (106). At least one first opening (118) is configured in the cover (116) for each chamber (110, 112), through which opening the chamber (110, 112) may be filled with a filling material. A closure (136) is provided, which seals the first opening (118). To produce the foil cartridge, the chamber (110, 112) is established by connecting the cover (116) with the foil tube (106). Then the chamber (110, 112) is filled with a filling material through the first opening (118) in the cover (116) and the first opening (118) is sealed. Fig. 1 Fig. 1 116 118 116 118 - 1112 108 ~120 120 102 +-102
Patent AU-2012203027-A1 (AU)
Title: Gaming machine
Inventor: OKADA KAZUO
IPC: G07F17/32
Filed: 2012-05-23
Abstract: Abstract A gaming machine for changing a payout ratio through technical intervention of a player is provided. The gaming machine comprises: a display arranging a plurality of symbols; and a control section executing a first game rearranging the plurality of symbols with a preset payout ratio, and awarding a payout to a player on the basis of a result of the first game, and executing a payout ratio increasing game that increases the payout ratio and is only executable when predetermined conditions are satisfied, and awarding a payout to the player on the basis of a result of the payout ratio increasing game, wherein the control section executes the payout ratio increasing game, in which the preset payout ratio changes in a predetermined range. AYOUT RATIO INCREASING GAME PROCESS -S31 ACTIVATE ACCEPTANCE OF AN OPERATION WHETHER THE NO -<,' HAS BEEN AN OPERATION S33 WITHIN A TIM S YES AUTOMA~~1C GAME PAYOUT RATIO INCREASING GAME PROCESS WHETHER THE INPUT IS DISPLAY A FAILURE DISPLAY A SUCCESS IMAGE IMAGE s AWARD A PAYOUT CALCULATE AND DISPLAY -3 A PAYOUT RATIO - ~ THE PAYOUT RATIO IS <- AN END CONDITION S SATISFIED ,I YES DEACTIVATE ACCEPTNANCES4 OF AN OPERATION ( END )
Patent AU-2012207073-A1 (AU)
Title: Negotiating capabilities between a wireless sink and a wireless source device
Inventor: RAVEENDRAN VIJAYALAKSHMI R
IPC: H04W28/18
Filed: 2012-01-20
Abstract: As part of a communication session, a wireless source device can transmit audio and video data to a wireless sink device, and the wireless sink device can transmit user inputs received at the wireless sink device back to the wireless source device. In this manner, a user of the wireless sink device can control the wireless source device and control the content that is being transmitted from the wireless source device to the wireless sink device. As part of establishing the communication session, the wireless sink device and the wireless source device may perform capability negotiation.
Patent AU-2012209007-A1 (AU)
Title: Low friction sheave bracket
Inventor: FELIX STEPHEN
IPC: E21F13/02
Filed: 2012-07-31
Abstract: An electrically powered mining vehicle including a frame rollingly supported on a surface for movement over the surface. An electric motor is coupled to the frame for proving power to the vehicle. A cable is electrically coupled to the electric motor for 5 supplying electricity thereto and a cable management system is coupled to the frame and arranged to receive and payout the cable as the vehicle moves over the surface. A sheave bracket is coupled to the frame and arranged to direct the cable into the cable management system and includes a lower plate arranged substantially horizontally, a plurality of vertical rollers that are coupled to the lower plate and are arranged to guide 10 the cable into the cable management system, and a horizontal roller that is coupled to the lower plate and arranged to elevate the cable above the lower plate. r i - --- -II- - - I ~ ~ ~ ~ ' r rri 1rirr 4 I,
Patent AU-2012213549-A1 (AU)
Title: Aerated food products
Inventor: ARNAUDOV LUBEN NIKOLAEV
IPC: A23L23/00
Filed: 2012-01-31
Abstract: The present invention has as an objective to provide aerated food products containing hydrophobins, and proteins which do not interfere with hydrophobins, and of which the texture remains stable during storage. This objective is met by an aerated food product which contains aggregated protein particles which are not surface active.
Patent AU-2012214553-A1 (AU)
Title: Multiparticulate L-menthol formulations and related methods
Inventor: SHAH SYED M
IPC: A01N25/34
Filed: 2012-02-07
Abstract: Enteric coated multiparticulate formulations that use L- menthol as an active ingredient are disclosed. In one embodiment, the multiparticulate formulation comprises a plurality of particulates having a reduced release under gastric conditions and an elevated release at neutral pH. The particulates comprise a core comprising L-menthol as an active ingredient. The L-menthol is supplied to the core as an at least 80% pure L-menthol material. An enteric coating is over the core. The enteric coating is effective to release at least about 80% of the L-menthol within about two hours of being placed in a substantially neutral pH environment. Other aspects of the invention include methods of making and methods of using the multiparticulate formulations.
Patent AU-2012244188-A1 (AU)
Title: New Process for the Synthesis of Ivabradine and Addition Salts Thereof with a Pharmaceutically Acceptable Acid
Inventor: RENAUD JEAN-LUC
IPC: C07D223/16
Filed: 2012-10-24
Abstract: NEW PROCESS FOR THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID Abstract The invention relates to a process for the synthesis of ivabradine of formula (I): addition salts thereof with a pharmaceutically acceptable acid, and hydrates thereof.